Rodman David Malcom

Chief Medical Officer

Rodman David Malcom has filed 8 SEC Form 4 filings (52 transaction rows) across 1 company, with disclosures dating back to 2026. 8 of those filings fall inside the rolling window. Most recent filing: Jul 16, 2026.

Companies traded

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$12.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MLYSSale$388KJul 16SEC ↗
MLYSSale$169KJul 16SEC ↗
MLYSSale$66KJul 10SEC ↗
MLYSSale$235KJun 18SEC ↗
MLYSSale$115KJun 18SEC ↗
MLYSSale$65KMay 14SEC ↗
MLYSSale$186KMay 14SEC ↗
MLYSSale$402KMay 14SEC ↗
MLYSSale$373KApr 15SEC ↗
MLYSSale$176KApr 15SEC ↗
MLYSSale$174KMar 16SEC ↗
MLYSSale$369KMar 16SEC ↗
MLYSSale$184KFeb 13SEC ↗
MLYSSale$386KFeb 13SEC ↗
MLYSSale$2.5MJan 6SEC ↗
MLYSSale$6.7MJan 6SEC ↗